Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema

A. Yoshioka, Tomoko Betsuyaku, M. Nishimura, K. Miyamoto, T. Kondo, Y. Kawakami

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

In an attempt to further evaluate the role of neutrophil elastase (NE) in the development of emphysema, we examined the immunologic quantity of NE bound to α1-protease inhibitor (PI), the NE inhibitory activity, and the molecular pattern of α1-PI in unconcentrated bronchoalveolar lavage fluid (BALF) supernatant from 36 community-based older volunteers. They were classified into three groups: 10 current smokers with low attenuation areas (LAAs) on the lung computed tomography (CT) scans who were considered to have subclinical emphysema, 13 current smokers who had a comparable smoking history but no LAA, and 13 noncurrent smokers without LAA. The concentration of NE-α1-PI complex was significantly increased in the subjects with subclinical emphysema when compared not only with the noncurrent smokers (0.52 ± 0.10 versus 0.21 ± 0.03 SEM μg/mg albumin, p < 0.01) but also with the LAA(-) current smokers (0.52 ± 0.10 versus 0.23 ± 0.07 SEM μg/mg albumin, p < 0.01). NE inhibitory activity measured by a spectrophotometric method using methoxysuccinyl-alanyl-alanyl-prolyl-valyl-paranitroanilide did not show any significant difference between the two groups of current smokers. There was no difference in the pattern or density of native and proteolysed α1-PI bands between the three groups by Western blotting. We conclude that NE-α1-PI complex in BALF is a factor that may differentiate smokers who are potentially developing emphysema from those who are not.

Original languageEnglish
Pages (from-to)2127-2132
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume152
Issue number6 I
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Leukocyte Elastase
Emphysema
Bronchoalveolar Lavage Fluid
Protease Inhibitors
Albumins
Volunteers
Western Blotting
Smoking
History
Tomography
Lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Yoshioka, A., Betsuyaku, T., Nishimura, M., Miyamoto, K., Kondo, T., & Kawakami, Y. (1995). Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. American Journal of Respiratory and Critical Care Medicine, 152(6 I), 2127-2132.

Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. / Yoshioka, A.; Betsuyaku, Tomoko; Nishimura, M.; Miyamoto, K.; Kondo, T.; Kawakami, Y.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 152, No. 6 I, 1995, p. 2127-2132.

Research output: Contribution to journalArticle

Yoshioka, A, Betsuyaku, T, Nishimura, M, Miyamoto, K, Kondo, T & Kawakami, Y 1995, 'Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema', American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 6 I, pp. 2127-2132.
Yoshioka A, Betsuyaku T, Nishimura M, Miyamoto K, Kondo T, Kawakami Y. Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. American Journal of Respiratory and Critical Care Medicine. 1995;152(6 I):2127-2132.
Yoshioka, A. ; Betsuyaku, Tomoko ; Nishimura, M. ; Miyamoto, K. ; Kondo, T. ; Kawakami, Y. / Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. In: American Journal of Respiratory and Critical Care Medicine. 1995 ; Vol. 152, No. 6 I. pp. 2127-2132.
@article{274fe1d0ff3645b0a13ea6590c98e889,
title = "Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema",
abstract = "In an attempt to further evaluate the role of neutrophil elastase (NE) in the development of emphysema, we examined the immunologic quantity of NE bound to α1-protease inhibitor (PI), the NE inhibitory activity, and the molecular pattern of α1-PI in unconcentrated bronchoalveolar lavage fluid (BALF) supernatant from 36 community-based older volunteers. They were classified into three groups: 10 current smokers with low attenuation areas (LAAs) on the lung computed tomography (CT) scans who were considered to have subclinical emphysema, 13 current smokers who had a comparable smoking history but no LAA, and 13 noncurrent smokers without LAA. The concentration of NE-α1-PI complex was significantly increased in the subjects with subclinical emphysema when compared not only with the noncurrent smokers (0.52 ± 0.10 versus 0.21 ± 0.03 SEM μg/mg albumin, p < 0.01) but also with the LAA(-) current smokers (0.52 ± 0.10 versus 0.23 ± 0.07 SEM μg/mg albumin, p < 0.01). NE inhibitory activity measured by a spectrophotometric method using methoxysuccinyl-alanyl-alanyl-prolyl-valyl-paranitroanilide did not show any significant difference between the two groups of current smokers. There was no difference in the pattern or density of native and proteolysed α1-PI bands between the three groups by Western blotting. We conclude that NE-α1-PI complex in BALF is a factor that may differentiate smokers who are potentially developing emphysema from those who are not.",
author = "A. Yoshioka and Tomoko Betsuyaku and M. Nishimura and K. Miyamoto and T. Kondo and Y. Kawakami",
year = "1995",
language = "English",
volume = "152",
pages = "2127--2132",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6 I",

}

TY - JOUR

T1 - Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema

AU - Yoshioka, A.

AU - Betsuyaku, Tomoko

AU - Nishimura, M.

AU - Miyamoto, K.

AU - Kondo, T.

AU - Kawakami, Y.

PY - 1995

Y1 - 1995

N2 - In an attempt to further evaluate the role of neutrophil elastase (NE) in the development of emphysema, we examined the immunologic quantity of NE bound to α1-protease inhibitor (PI), the NE inhibitory activity, and the molecular pattern of α1-PI in unconcentrated bronchoalveolar lavage fluid (BALF) supernatant from 36 community-based older volunteers. They were classified into three groups: 10 current smokers with low attenuation areas (LAAs) on the lung computed tomography (CT) scans who were considered to have subclinical emphysema, 13 current smokers who had a comparable smoking history but no LAA, and 13 noncurrent smokers without LAA. The concentration of NE-α1-PI complex was significantly increased in the subjects with subclinical emphysema when compared not only with the noncurrent smokers (0.52 ± 0.10 versus 0.21 ± 0.03 SEM μg/mg albumin, p < 0.01) but also with the LAA(-) current smokers (0.52 ± 0.10 versus 0.23 ± 0.07 SEM μg/mg albumin, p < 0.01). NE inhibitory activity measured by a spectrophotometric method using methoxysuccinyl-alanyl-alanyl-prolyl-valyl-paranitroanilide did not show any significant difference between the two groups of current smokers. There was no difference in the pattern or density of native and proteolysed α1-PI bands between the three groups by Western blotting. We conclude that NE-α1-PI complex in BALF is a factor that may differentiate smokers who are potentially developing emphysema from those who are not.

AB - In an attempt to further evaluate the role of neutrophil elastase (NE) in the development of emphysema, we examined the immunologic quantity of NE bound to α1-protease inhibitor (PI), the NE inhibitory activity, and the molecular pattern of α1-PI in unconcentrated bronchoalveolar lavage fluid (BALF) supernatant from 36 community-based older volunteers. They were classified into three groups: 10 current smokers with low attenuation areas (LAAs) on the lung computed tomography (CT) scans who were considered to have subclinical emphysema, 13 current smokers who had a comparable smoking history but no LAA, and 13 noncurrent smokers without LAA. The concentration of NE-α1-PI complex was significantly increased in the subjects with subclinical emphysema when compared not only with the noncurrent smokers (0.52 ± 0.10 versus 0.21 ± 0.03 SEM μg/mg albumin, p < 0.01) but also with the LAA(-) current smokers (0.52 ± 0.10 versus 0.23 ± 0.07 SEM μg/mg albumin, p < 0.01). NE inhibitory activity measured by a spectrophotometric method using methoxysuccinyl-alanyl-alanyl-prolyl-valyl-paranitroanilide did not show any significant difference between the two groups of current smokers. There was no difference in the pattern or density of native and proteolysed α1-PI bands between the three groups by Western blotting. We conclude that NE-α1-PI complex in BALF is a factor that may differentiate smokers who are potentially developing emphysema from those who are not.

UR - http://www.scopus.com/inward/record.url?scp=0028856719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028856719&partnerID=8YFLogxK

M3 - Article

C2 - 8520785

AN - SCOPUS:0028856719

VL - 152

SP - 2127

EP - 2132

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6 I

ER -